Cargando…

Chinese Medicine for Chronic Obstructive Pulmonary Disease: A Pilot Study on Patient Preferences

PURPOSE: The patient’s preference plays an important role in clinical practice. There currently is no available evidence regarding the perception and attitudes of patients with chronic obstructive pulmonary disease (COPD) towards the use of Chinese medicine (CM) approaches. This study was designed t...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Shaonan, Lai, Jiaqi, Wu, Lei, Guo, Xinfeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8275201/
https://www.ncbi.nlm.nih.gov/pubmed/34267508
http://dx.doi.org/10.2147/PPA.S316872
_version_ 1783721685825880064
author Liu, Shaonan
Lai, Jiaqi
Wu, Lei
Guo, Xinfeng
author_facet Liu, Shaonan
Lai, Jiaqi
Wu, Lei
Guo, Xinfeng
author_sort Liu, Shaonan
collection PubMed
description PURPOSE: The patient’s preference plays an important role in clinical practice. There currently is no available evidence regarding the perception and attitudes of patients with chronic obstructive pulmonary disease (COPD) towards the use of Chinese medicine (CM) approaches. This study was designed to explore preferences and factors associated with CM among COPD patients. PATIENTS AND METHODS: A pilot survey was conducted among COPD patients using a structured, pre-tested questionnaire. The perceptions of CM therapies (including herbal medicine, non-pharmacotherapies), and expected clinical outcomes were investigated based on patient preference. Factors associated with preference of treatment scenarios were estimated in order of importance. RESULTS: Thirty patients were enrolled in the survey, including 27 males and 3 females. Two-thirds of the patients preferred integrative Chinese and Western medicine for the treatment of COPD. Chinese patent medicines and CM decoction therapy were more popular than CM injections. The preferred non-drug therapy was point application, followed by acupuncture, Tai chi, or Qigong. More than 70% of patients reported that important clinical outcomes were improvements in lung function (77%) and dyspnea, cough, and sputum symptoms (73%), followed by exercise endurance (50%). Besides clinical efficacy, costs and side effects were also important factors for treatment selection. CONCLUSION: This pilot study showed that Chinese patent medicine and CM decoctions were preferred options for complementary medicines to combine with routine pharmacotherapy for COPD treatment according to the patients’ preferences. The improvement of dyspnea, cough symptoms, and lung function was the most desired clinical outcomes for patients. Quicker symptom relief, lower costs, and fewer side effects were key attributes for the treatment selection. Further research with a larger sample size is needed to definitively address the comprehensive conclusion.
format Online
Article
Text
id pubmed-8275201
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-82752012021-07-14 Chinese Medicine for Chronic Obstructive Pulmonary Disease: A Pilot Study on Patient Preferences Liu, Shaonan Lai, Jiaqi Wu, Lei Guo, Xinfeng Patient Prefer Adherence Original Research PURPOSE: The patient’s preference plays an important role in clinical practice. There currently is no available evidence regarding the perception and attitudes of patients with chronic obstructive pulmonary disease (COPD) towards the use of Chinese medicine (CM) approaches. This study was designed to explore preferences and factors associated with CM among COPD patients. PATIENTS AND METHODS: A pilot survey was conducted among COPD patients using a structured, pre-tested questionnaire. The perceptions of CM therapies (including herbal medicine, non-pharmacotherapies), and expected clinical outcomes were investigated based on patient preference. Factors associated with preference of treatment scenarios were estimated in order of importance. RESULTS: Thirty patients were enrolled in the survey, including 27 males and 3 females. Two-thirds of the patients preferred integrative Chinese and Western medicine for the treatment of COPD. Chinese patent medicines and CM decoction therapy were more popular than CM injections. The preferred non-drug therapy was point application, followed by acupuncture, Tai chi, or Qigong. More than 70% of patients reported that important clinical outcomes were improvements in lung function (77%) and dyspnea, cough, and sputum symptoms (73%), followed by exercise endurance (50%). Besides clinical efficacy, costs and side effects were also important factors for treatment selection. CONCLUSION: This pilot study showed that Chinese patent medicine and CM decoctions were preferred options for complementary medicines to combine with routine pharmacotherapy for COPD treatment according to the patients’ preferences. The improvement of dyspnea, cough symptoms, and lung function was the most desired clinical outcomes for patients. Quicker symptom relief, lower costs, and fewer side effects were key attributes for the treatment selection. Further research with a larger sample size is needed to definitively address the comprehensive conclusion. Dove 2021-07-08 /pmc/articles/PMC8275201/ /pubmed/34267508 http://dx.doi.org/10.2147/PPA.S316872 Text en © 2021 Liu et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Liu, Shaonan
Lai, Jiaqi
Wu, Lei
Guo, Xinfeng
Chinese Medicine for Chronic Obstructive Pulmonary Disease: A Pilot Study on Patient Preferences
title Chinese Medicine for Chronic Obstructive Pulmonary Disease: A Pilot Study on Patient Preferences
title_full Chinese Medicine for Chronic Obstructive Pulmonary Disease: A Pilot Study on Patient Preferences
title_fullStr Chinese Medicine for Chronic Obstructive Pulmonary Disease: A Pilot Study on Patient Preferences
title_full_unstemmed Chinese Medicine for Chronic Obstructive Pulmonary Disease: A Pilot Study on Patient Preferences
title_short Chinese Medicine for Chronic Obstructive Pulmonary Disease: A Pilot Study on Patient Preferences
title_sort chinese medicine for chronic obstructive pulmonary disease: a pilot study on patient preferences
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8275201/
https://www.ncbi.nlm.nih.gov/pubmed/34267508
http://dx.doi.org/10.2147/PPA.S316872
work_keys_str_mv AT liushaonan chinesemedicineforchronicobstructivepulmonarydiseaseapilotstudyonpatientpreferences
AT laijiaqi chinesemedicineforchronicobstructivepulmonarydiseaseapilotstudyonpatientpreferences
AT wulei chinesemedicineforchronicobstructivepulmonarydiseaseapilotstudyonpatientpreferences
AT guoxinfeng chinesemedicineforchronicobstructivepulmonarydiseaseapilotstudyonpatientpreferences